4//SEC Filing
Cahill Brian Joseph 4
Accession 0001209191-21-004924
CIK 0000827871other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 5:21 PM ET
Size
7.7 KB
Accession
0001209191-21-004924
Insider Transaction Report
Form 4
Cahill Brian Joseph
Chief Financial Officer
Transactions
- Award
Common Stock
2020-12-18+5,000→ 19,303 total - Award
Employee Stock Option (Right to Buy)
2020-12-18+10,000→ 10,000 totalExercise: $48.09Exp: 2030-12-18→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock units ("RSUs"). The RSUs vest over a period of four years, with 25% of the RSUs vesting on each of the one, two, three and four-year anniversaries of December 18, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The option vests over a period of four years, with 25% of the shares underlying the option vesting on October 29, 2021, and the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeother
Related Parties
1- filerCIK 0001831591
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 5:21 PM ET
- Size
- 7.7 KB